Potter M - Search Results

1

Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.

Gerrard G, Payne E, Baker RJ, Jones DT, Potter M, Prentice HG, Ethell M, McCullough H, Burgess M, Mehta AB, Ganeshaguru K. Gerrard G, et al. Among authors: potter m. Haematologica. 2004 Jul;89(7):782-90. Haematologica. 2004. PMID: 15257929 Clinical Trial.

2

Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes.

Virchis A, Koh M, Rankin P, Mehta A, Potter M, Hoffbrand AV, Prentice HG. Virchis A, et al. Among authors: potter m. Br J Haematol. 2004 Jan;124(1):26-32. doi: 10.1046/j.1365-2141.2003.04728.x. Br J Haematol. 2004. PMID: 14675405 Free article. Clinical Trial.

3

The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.

Burnett AK, Milligan D, Goldstone A, Prentice A, McMullin MF, Dennis M, Sellwood E, Pallis M, Russell N, Hills RK, Wheatley K; United Kingdom National Cancer Research Institute Haematological Oncology Study Group. Burnett AK, et al. Br J Haematol. 2009 May;145(3):318-32. doi: 10.1111/j.1365-2141.2009.07604.x. Epub 2009 Mar 8. Br J Haematol. 2009. PMID: 19291085 Free article. Clinical Trial.

4

Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia.

Gameiro P, Moreira I, Yetgin S, Papaioannou M, Potter MN, Prentice HG, Hoffbrand AV, Foroni L. Gameiro P, et al. Among authors: potter mn. Br J Haematol. 2002 Dec;119(3):685-96. doi: 10.1046/j.1365-2141.2002.03911.x. Br J Haematol. 2002. PMID: 12437645 Free article.

5

High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experience.

Carceller F, Hirsch SG, Khabra K, Petterson T, Malik R, Guerra-García P, Moreno L, Marshall LV, Taj M, Atra A, Ethell M, Potter M, Lancaster D. Carceller F, et al. Among authors: potter m. Leuk Res. 2019 Oct;85:106217. doi: 10.1016/j.leukres.2019.106217. Epub 2019 Aug 13. Leuk Res. 2019. PMID: 31493701

6

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

Pawson R, Potter MN, Theocharous P, Lawler M, Garg M, Yin JA, Rezvani K, Craddock C, Rassam S, Prentice HG. Pawson R, et al. Among authors: potter mn. Br J Haematol. 2001 Dec;115(3):622-9. doi: 10.1046/j.1365-2141.2001.03150.x. Br J Haematol. 2001. PMID: 11736947 Free article.

7

ANCA +ve vasculitis after autologous PBSC transplantation.

Kingdon EJ, Johnston RE, Pawson R, Prentice HG, Potter MN, Burns A, Powis SH. Kingdon EJ, et al. Nephrol Dial Transplant. 2002 Feb;17(2):285-7. doi: 10.1093/ndt/17.2.285. Nephrol Dial Transplant. 2002. PMID: 11812882 No abstract available.

8

Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments.

Alvares CL, Davies FE, Horton C, Patel G, Powles R, Sirohi B, Zuha R, Gatt A, Saso R, Treleaven JG, Dearden CE, Potter MN, Ethell ME, Morgan GJ. Alvares CL, et al. Br J Haematol. 2005 Jun;129(5):607-14. doi: 10.1111/j.1365-2141.2005.05514.x. Br J Haematol. 2005. PMID: 15916682 Free article.

9

The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.

Paterson PJ, McWhinney PH, Potter M, Kibbler CC, Prentice HG. Paterson PJ, et al. Among authors: potter m. Br J Haematol. 2001 Jan;112(1):175-80. doi: 10.1046/j.1365-2141.2001.02486.x. Br J Haematol. 2001. PMID: 11167799 Free article.

10

Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients.

Fallen PR, McGreavey L, Madrigal JA, Potter M, Ethell M, Prentice HG, Guimarães A, Travers PJ. Fallen PR, et al. Among authors: potter m. Bone Marrow Transplant. 2003 Nov;32(10):1001-14. doi: 10.1038/sj.bmt.1704235. Bone Marrow Transplant. 2003. PMID: 14595388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,528 results

Search Page

Filters